| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.14 | 0.001 |